Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-19 Purchase | 2022-08-22 7:00 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director | 38,000 | $148.04 | $5,625,676 | 2,583,658 (Direct) | View |
| 2022-05-10 Sale | 2022-05-12 8:58 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 4,200 | $141.5 | $594,300 | 6,315 (Direct) | View |
| 2020-06-15 Sale(A) | 2022-02-11 9:41 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 41,306 | $68.49 | $2,829,152 | 999,914 (Indirect Direct) | View |
| 2020-06-11 Sale(A) | 2022-02-11 9:40 pm | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 50,953 | $65.19 | $3,321,623 | 1,139,915 (Indirect Direct) | View |
| 2022-01-19 Sale | 2022-01-24 06:01 am | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 9,375 | $117.01 | $1,097,003 | 13,390 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-10-03 Other | 2022-10-05 5:40 pm | N/A N/A | Biohaven Ltd. | BHVN | Biohaven Pharmaceutical Holding Co Ltd. 10% Owner | 35,839,857 | $0 | 71,679,714 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 15,900 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:30 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Engelhart James Strategic Advisor | 383,506 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:29 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director | 3,035,001 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:29 pm | N/A 2032-04-28 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director | 20,235 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:28 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 6,177 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:28 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 63,500 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:27 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director | 10,640 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:27 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director | 58,118 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:27 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 6,682 | $148.5 | 1,614 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:27 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 126,407 | $0 | 1,614 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:26 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer | 922,941 | $148.5 | 830,891 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:26 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer | 1,278,454 | $0 | 830,891 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:26 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director | 49,755 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A 2032-04-28 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director | 56,235 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 14,226 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | JONES WILLIAM A JR CCO-Migraine & Common Disease | 174,250 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director | 2,900 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director | 42,600 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:25 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Antonijevic Irina Director | 5,070 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:24 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 4,292 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:24 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 55,125 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director | 2,583,658 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A 2032-04-28 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director | 56,235 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 16,464 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 202,851 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 22,362 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:23 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 274,727 | $0 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:20 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations | 11,653 | $148.5 | 0 (Direct) | View |
| 2022-10-03 Disposition | 2022-10-03 8:20 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Gentile Kimberly SVP, Clinical Operations | 255,272 | $0 | 0 (Direct) | View |
Ownership | 2022-09-28 8:50 pm | N/A N/A | Biohaven Ltd. | BHVN | Biohaven Pharmaceutical Holding Co Ltd. 10% Owner | 0 | $0 | 100 (Direct) | View |
| 2022-05-10 Exercise | 2022-05-12 8:58 pm | N/A 2029-12-05 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 2,250 | $0 | 6,315 (Direct) | View |
| 2022-05-10 Exercise | 2022-05-12 8:58 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 2,250 | $53.76 | 6,315 (Direct) | View |
| 2022-05-11 Option Award | 2022-05-12 8:57 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Antonijevic Irina Director | 5,070 | $0 | 5,070 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:04 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:03 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | GREGORY JULIA P Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:02 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | CHILDS JOHN W Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 9:00 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | HUGIN ROBERT J Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 8:59 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Bailey Gregory Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2022-04-28 Option Award | 2022-04-29 8:58 pm | N/A 2032-04-27 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Heffernan Michael Thomas Director | 8,239 | $0 | 8,239 (Direct) | View |
| 2021-03-08 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 1,474,051 | $0 | 1,308,989 (Direct) | View |
| 2021-05-21 Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 170,000 | $0 | 1,308,989 (Indirect) | View |
Ownership | 2022-02-11 9:44 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Doogan Declan Director | 0 | $0 | 1,308,989 (Indirect) | View |
| 2021-06-21 Ownership | 2022-02-11 9:15 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer | 47,283 | $0 | 387,985 (Indirect) | View |
Ownership | 2022-02-11 9:15 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Coric Vlad Chief Executive Officer | 0 | $0 | 387,985 (Indirect) | View |
| 2022-01-19 Exercise | 2022-01-24 06:01 am | N/A 2029-12-05 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 5,670 | $0 | 13,390 (Direct) | View |
| 2022-01-19 Exercise | 2022-01-24 06:01 am | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 3,750 | $53.76 | 13,390 (Direct) | View |
| 2022-01-19 Exercise | 2022-01-24 06:01 am | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 1,920 | $32.42 | 13,390 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-12 9:12 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 1,000 | $0 | 10,720 (Direct) | View |
| 2022-01-10 Tax Withholding | 2022-01-12 9:12 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 464 | $128.87 | 10,720 (Direct) | View |
| 2022-01-10 Exercise | 2022-01-12 9:10 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Stock Elyse Chief Medical Officer | 937 | $0 | 17,402 (Indirect) | View |
| 2022-01-10 Exercise | 2022-01-12 9:04 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Mehta Kishan Director | 1,875 | $0 | 12,515 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:19 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Buten Matthew Chief Financial Officer | 26,000 | $0 | 26,000 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 2,125 | $0 | 22,176 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 551 | $123.86 | 22,176 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 10,500 | $0 | 22,176 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Tilton John Chief Commercial Officer | 342 | $128.87 | 22,176 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 1,875 | $0 | 29,934 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 409 | $123.86 | 29,934 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 15,000 | $0 | 29,934 (Direct) | View |
| 2022-01-07 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Clark George C. VP, Chief Accounting Officer | 522 | $128.87 | 29,934 (Direct) | View |
| 2022-01-06 Exercise | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 3,750 | $0 | 64,135 (Direct) | View |
| 2022-01-06 Tax Withholding | 2022-01-07 9:18 pm | N/A N/A | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 1,800 | $123.86 | 64,135 (Direct) | View |
| 2022-01-07 Option Award | 2022-01-07 9:18 pm | N/A 2032-01-07 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Conway Charles Chief Scientific Officer | 34,500 | $0 | 64,135 (Direct) | View |